Article info
PDFCommentary
General medicine
CETP inhibition improves the lipid profile but has no effect on clinical cardiovascular outcomes in high-risk patients
- Correspondence to Professor Robert S Rosenson, Cardiometabolics Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Hospital Box 1031, New York, NY 10029, USA; robert.rosenson{at}mssm.edu
Citation
CETP inhibition improves the lipid profile but has no effect on clinical cardiovascular outcomes in high-risk patients
Publication history
- First published August 26, 2017.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.